Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to Economics test |u:www.enterprize.cam.ac.uk.  Search for Economics test |u:www.enterprise.cam.ac.uk instead.
61 - 66 of 66 search results for Economics test |u:www.enterprise.cam.ac.uk or Economics test |u:www.enterprize.cam.ac.uk where 5 match all words and 61 match some words.
  1. Results that match 1 of 2 words

  2. Cambridge joins consortium to launch £40 million Apollo fund to drive …

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-joins-consortium-world-leading-uk-universities-global-pharmaceutical-companies-launch-40-million-fund-drive-therapeutic-innovation/
    Thumbnail for Cambridge joins consortium to launch £40 million Apollo fund to drive therapeutic innovation – Cambridge Enterprise 22 Feb 2023: valuable proposition for any academic or company that wants to see early stage ground breaking therapeutic technology progress to the clinic for patient benefit and economic return. ... for patient benefit and economic return.”.
  3. University of Cambridge breaks its early stage investment record for…

    https://www.enterprise.cam.ac.uk/news/university-of-cambridge-breaks-its-early-stage-investment-record-for-the-fourth-consecutive-year/
    Thumbnail for University of Cambridge breaks its early stage investment record for the fourth consecutive year – Cambridge Enterprise 22 Feb 2023: This was the fourth year of operation for the Enterprise Fund, which was announced as part of the SEIS programme in the government’s 2012 budget, established to stimulate economic growth.
  4. Portfolio company Mission Therapeutics awarded research grant from…

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-portfolio-company-mission-therapeutics-awarded-research-grant-from-the-michael-j-fox-foundation/
    Thumbnail for Portfolio company Mission Therapeutics awarded research grant from the Michael J Fox Foundation – Cambridge Enterprise 22 Feb 2023: The objective of the research collaboration with Prof Wade-Martins is to test Mission’s potent and selective USP30 inhibitors in a range of disease models—induced Pluripotent Stem Cells ... There is no objective test, or biomarker, for Parkinson’s
  5. Leading universities and VCs publish unique USIT Guide to accelerate…

    https://www.enterprise.cam.ac.uk/news/leading-universities-and-vcs-publish-unique-usit-guide-to-accelerate-university-spin-outs-and-boost-uk-growth-2/
    Thumbnail for Leading universities and VCs publish unique USIT Guide to accelerate university spin-outs and boost UK growth – Cambridge Enterprise 19 May 2023: The USIT guide will enable the investment community to work more closely with our universities to create high impact businesses that can drive UK economic growth.
  6. New agreement with Cambridge spin-out PredictImmune lets SLE join…

    https://www.enterprise.cam.ac.uk/news/new-agreement-with-university-spin-out-predictimmune-allows-product-pipeline-to-include-systemic-lupus-erythematosus/
    Thumbnail for New agreement with Cambridge spin-out PredictImmune lets SLE join pipeline – Cambridge Enterprise 22 Feb 2023: As with IBD, patients with SLE can present with a variable disease course, and it is this variability that makes it an ideal choice for the development of a prognostic test
  7. Zetta Genomics secures £1.8 million in second round seed funding to…

    https://www.enterprise.cam.ac.uk/news/zetta-genomics-secures-1-8-million-in-second-round-seed-funding-to-configure-for-scale-delivery-and-innovation/
    Thumbnail for Zetta Genomics secures £1.8 million in second round seed funding to configure for scale, delivery and innovation – Cambridge Enterprise 20 Apr 2023: Preventing avoidable conditions and treating disease efficiently and effectively, we will see radical improvements not just in health, but health economics.

Refine your results

Format

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.